Wenzhou Kangning Hospital Co., Ltd. (2120.HK)
HKD 9.14
(0.22%)
HKD 9.14
(0.22%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.63 Billion CNY | 24.97% |
| 2022 | 1.31 Billion CNY | 18.52% |
| 2021 | 1.1 Billion CNY | 18.44% |
| 2020 | 934.52 Million CNY | 9.19% |
| 2019 | 855.84 Million CNY | 34.68% |
| 2018 | 635.45 Million CNY | 9.58% |
| 2017 | 579.9 Million CNY | 3.18% |
| 2016 | 562.01 Million CNY | 114.34% |
| 2015 | 262.2 Million CNY | 135.69% |
| 2014 | 111.24 Million CNY | 59.45% |
| 2013 | 69.77 Million CNY | -65.56% |
| 2012 | 202.6 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q4 | 1.63 Billion CNY | 0.0% |
| 2023 Q1 | 1.36 Billion CNY | 3.8% |
| 2023 FY | 1.63 Billion CNY | 24.97% |
| 2023 Q3 | 1.63 Billion CNY | 20.4% |
| 2023 Q2 | 1.36 Billion CNY | 0.0% |
| 2022 Q2 | 1.33 Billion CNY | 0.0% |
| 2022 FY | 1.31 Billion CNY | 18.52% |
| 2022 Q4 | 1.31 Billion CNY | 0.0% |
| 2022 Q3 | 1.31 Billion CNY | -2.06% |
| 2022 Q1 | 1.33 Billion CNY | 21.01% |
| 2021 Q2 | 1.03 Billion CNY | 0.0% |
| 2021 Q4 | 1.1 Billion CNY | 0.84% |
| 2021 Q3 | 1.09 Billion CNY | 5.67% |
| 2021 FY | 1.1 Billion CNY | 18.44% |
| 2021 Q1 | 1.03 Billion CNY | 11.16% |
| 2020 Q2 | 960.48 Million CNY | 0.0% |
| 2020 FY | 934.52 Million CNY | 9.19% |
| 2020 Q4 | 934.52 Million CNY | -2.2% |
| 2020 Q3 | 955.55 Million CNY | -0.51% |
| 2020 Q1 | 960.48 Million CNY | 12.23% |
| 2019 Q4 | 855.84 Million CNY | 0.0% |
| 2019 Q3 | 855.84 Million CNY | 13.91% |
| 2019 Q2 | 751.35 Million CNY | 0.0% |
| 2019 Q1 | 751.35 Million CNY | 18.24% |
| 2019 FY | 855.84 Million CNY | 34.68% |
| 2018 Q4 | 635.45 Million CNY | 0.0% |
| 2018 Q3 | 635.45 Million CNY | 10.78% |
| 2018 Q2 | 573.63 Million CNY | 0.0% |
| 2018 Q1 | 573.63 Million CNY | -1.08% |
| 2018 FY | 635.45 Million CNY | 9.58% |
| 2017 Q4 | 579.9 Million CNY | 0.0% |
| 2017 Q2 | 689.66 Million CNY | 0.0% |
| 2017 Q1 | 689.66 Million CNY | 22.71% |
| 2017 Q3 | 579.9 Million CNY | -15.92% |
| 2017 FY | 579.9 Million CNY | 3.18% |
| 2016 FY | 562.01 Million CNY | 114.34% |
| 2016 Q2 | 308.8 Million CNY | 0.0% |
| 2016 Q4 | 562.01 Million CNY | 0.0% |
| 2016 Q3 | 562.01 Million CNY | 82.0% |
| 2016 Q1 | 308.8 Million CNY | 17.77% |
| 2015 Q2 | 106.32 Million CNY | 0.0% |
| 2015 FY | 262.2 Million CNY | 135.69% |
| 2015 Q4 | 262.2 Million CNY | 75.86% |
| 2015 Q3 | 149.1 Million CNY | 40.23% |
| 2015 Q1 | 106.32 Million CNY | 25.97% |
| 2014 Q4 | 84.4 Million CNY | 0.0% |
| 2014 FY | 111.24 Million CNY | 59.45% |
| 2014 Q3 | 84.4 Million CNY | 0.0% |
| 2013 FY | 69.77 Million CNY | -65.56% |
| 2012 FY | 202.6 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aidigong Maternal & Child Health Limited | 1.2 Billion HKD | -36.145% |
| UMP Healthcare Holdings Limited | 362.14 Million HKD | -352.714% |
| Human Health Holdings Limited | 289.7 Million HKD | -465.91% |
| EuroEyes International Eye Clinic Limited | 588.09 Million HKD | -178.781% |
| Kato (Hong Kong) Holdings Limited | 428.77 Million HKD | -282.365% |
| Bamboos Health Care Holdings Limited | 99.73 Million HKD | -1543.82% |
| Beijing Health (Holdings) Limited | 223.82 Million HKD | -632.49% |
| C-MER Eye Care Holdings Limited | 755.34 Million HKD | -117.049% |
| Town Health International Medical Group Limited | 881.82 Million HKD | -85.92% |
| Medicskin Holdings Limited | 32.47 Million HKD | -4947.818% |
| Hang Chi Holdings Limited | 100.92 Million HKD | -1524.39% |